Related to Seegene Completes $16.6M IPO to Fund Expansion of MDx Kits in the U.S. and Japan

• Epigenomics Grants Predictive Biosciences Rights to Use a Biomarker in a Prostate Cancer Test
  
• Genetic Profile Found that Predicts Best Chemotherapy for Ovarian Cancers
  
• Alethia Licenses Preclinical Cancer mAbs for Drug and Diagnostic Development
  
• Diatherix Releases Swine Flu Virus Test
  
• Roche Launches Swine Flu Detection Kit for Research Purposes
  
• Collaboration Formed to Evaluate Epigenomics’ Test in Detecting Colorectal Polyps
  
• Blanchette Rockefeller Neurosciences Institute and Inverness Join Forces for Alzheimer's Diagnostic
  
• ExonHit Licenses IP for Breast Cancer Test from Institut Gustave Roussy
  
• Interleukin Genetics Introduces Weight Management Genetic Test
  
• Exact Sciences Closes $8.2M Placement and Inks Deal with Mayo Clinic
  
• Axis-Shield Acquires Rights to Develop Sepsis Diagnostic from Hansa Medical
  
• Swiss Viollier to Launch Colorectal Cancer Blood Test in Europe
  
• Castle Biosciences Chooses Phoenix Hospital to Offer Its Molecular Diagnostic for Brain Cancer
  
• Spinreact to Include AbD Serotec Antibodies in Clinical Diagnostic Kits
  
• Cepheid Gains FDA Approval for C. Difficile Molecular Diagnostic
  
• DxS and Epigenomics Cross-License Technologies for DNA Methylation In Vitro Diagnostics
  
• Axial Biotech Selects University of Utah Database to Develop Personalized Tests for Spine Disorders
  
• Cryopraxis to Assess Cryo-Cell's Menstrual Stem Cell Technology for Diagnosing Endometriosis
  
• QuantRx Creates Joint Venture with NuRx Focused on Point-of-Care Products
  
• MP Biomedicals to Develop Alzheimer’s Blood Test Based on UCLA Technology